Pursuant to Clause 9 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, Dr Diana Sarfati, Director-General of Health, exempt the following point-of-care rapid antigen test from all prohibitions under clause 7 of the Order.
Product name(s): LumiraDx SARS-CoV-2 Ag Test
Manufacturer (country): LumiraDx UK Ltd (United Kingdom)
Sample type(s): Nasal, nasopharyngeal swab
Product configuration: Professional Use of any package size
Dated at Wellington this 21st day of December 2022.
Dr DIANA SARFATI, Director-General of Health.